Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | SVP & General Counsel | August 28, 2026 | August 31, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date August 28, 2026 · Filed August 31, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,557 |
Ending reported balance
After 2026-08-28 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-08-28 · Exercise / conversion · Acquired 22,677 · Balance 60,234 F1: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Row 2 · 2026-08-28 · Sale · Disposed 16,010 · Balance 44,224 F1: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F2: This transaction was executed in multiple trades at prices ranging from $242.270 to $243.269. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 3 · 2026-08-28 · Sale · Disposed 6,237 · Balance 37,987 F1: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F3: This transaction was executed in multiple trades at prices ranging from $243.270 to $244.225. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 4 · 2026-08-28 · Sale · Disposed 430 · Balance 37,557 F1: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F4: This transaction was executed in multiple trades at prices ranging from $244.280 to $245.247. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 5 · 2026-08-28 · Gift · Disposed 1,000 · Balance 36,557 F5: On August 28, 2026, the reporting person made a charitable gift of 1,000 shares, a transaction eligible for deferred reporting on Form 5. The reporting person has chosen to report such transaction early on this Form 4. |
| Non-Qualifed Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $112.17 · Expires 2030-02-18 | Direct | 0 |
Reported balance
After 2026-08-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-28 · Exercise / conversion · Disposed 22,677 · Balance 0 F1: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F7: The options vested in three equal annual installments beginning on the first annual anniversary of the grant date. |
| Common StockSEC Table I · non-derivative | Indirect401(k)/SDCP | 5,780 |
Reported balance
Holding disclosure · report date 2026-08-28 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 5,780 F6: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. |
Filing footnotes · ownership attribution and instrument terms
F1: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
F2: This transaction was executed in multiple trades at prices ranging from $242.270 to $243.269. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $243.270 to $244.225. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $244.280 to $245.247. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5: On August 28, 2026, the reporting person made a charitable gift of 1,000 shares, a transaction eligible for deferred reporting on Form 5. The reporting person has chosen to report such transaction early on this Form 4.
F6: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
F7: The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2020 Filed Feb 21, 2020 01:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 3,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000031 · wf-form4_158224903048896.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,455 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GiftCommon Stock | 480 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000013 · wf-form4_158137060457901.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,978 F1 · shares: On February 7, 2020, the reporting person made a charitable gift of 480 shares. Read SEC document |
| November 27, 2019 Filed Dec 4, 2019 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 32,693 | $56.12 Strike: $56.12 | $1,834,731.16 |
DisclosureSEC source: 0001022079-19-000194 · wf-form4_157549512379632.xml · derivative · entry 8 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,693 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 25, 2014, the second on February 25, 2015 and the final on February 25, 2016. Read SEC document |
| November 27, 2019 Filed Dec 4, 2019 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 11,863 | $52.17 Strike: $52.17 | $618,833.40 |
DisclosureSEC source: 0001022079-19-000194 · wf-form4_157549512379632.xml · derivative · entry 7 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,591 Underlying: Common Stock · 11,863 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017. Read SEC document |
| November 27, 2019 Filed Dec 4, 2019 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 500 | $107.83 | $53,915.00 |
DisclosureSEC source: 0001022079-19-000194 · wf-form4_157549512379632.xml · nonDerivative · entry 5 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,458 Read SEC document |
| November 27, 2019 Filed Dec 4, 2019 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 32,193 | $107.53 | $3,461,552.33 |
DisclosureSEC source: 0001022079-19-000194 · wf-form4_157549512379632.xml · nonDerivative · entry 4 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,958 F2 · price: This transaction was executed in multiple trades at prices ranging from $106.80 to $107.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 27, 2019 Filed Dec 4, 2019 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 11,863 | $107.15 | $1,271,096.72 |
DisclosureSEC source: 0001022079-19-000194 · wf-form4_157549512379632.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,151 F1 · price: This transaction was executed in multiple trades at prices ranging from $107.03 to $107.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 27, 2019 Filed Dec 4, 2019 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 32,693 | $56.12 | $1,834,731.16 |
DisclosureSEC source: 0001022079-19-000194 · wf-form4_157549512379632.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2019 Filed Dec 4, 2019 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 11,863 | $52.17 | $618,833.40 |
DisclosureSEC source: 0001022079-19-000194 · wf-form4_157549512379632.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2019 Filed Mar 5, 2019 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 3,373 | $86.81 | $292,810.13 |
DisclosureSEC source: 0001022079-19-000093 · wf-form4_155182156106751.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,458 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 24, 2018. F4 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 3,274 | $86.86 | $284,379.64 |
DisclosureSEC source: 0001022079-19-000093 · wf-form4_155182156106751.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,826 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 6,647 | $86.86 | $577,358.42 |
DisclosureSEC source: 0001022079-19-000093 · wf-form4_155182156106751.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,100 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 25, 2016, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 22:24 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,048 | $86.51 | $90,662.48 |
DisclosureSEC source: 0001022079-19-000078 · wf-form4_155139268485919.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,453 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 24, 2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:24 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 364 | $87.06 | $31,689.84 |
DisclosureSEC source: 0001022079-19-000078 · wf-form4_155139268485919.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,501 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 24, 2018. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 22:24 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 907 | $87.84 | $79,670.88 |
DisclosureSEC source: 0001022079-19-000078 · wf-form4_155139268485919.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,865 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 23:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 336 | $88.23 | $29,645.28 |
DisclosureSEC source: 0001022079-19-000064 · wf-form4_155131043072799.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,772 F2 · shares: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 24, 2018. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 23:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 315 | $88.24 | $27,795.60 |
DisclosureSEC source: 0001022079-19-000064 · wf-form4_155131043072799.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,108 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 01:01 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 291 | $88.39 | $25,721.49 |
DisclosureSEC source: 0001022079-19-000045 · wf-form4_155114288184638.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,423 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 18, 2019 Filed Feb 20, 2019 23:30 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 35,146 | $0.00 Strike: $86.63 | $0.00 |
DisclosureSEC source: 0001022079-19-000024 · wf-form4_155070542873347.xml · derivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,146 Underlying: Common Stock · 35,146 shares Expires 2029-02-18 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2019 Filed Feb 20, 2019 23:30 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-19-000024 · wf-form4_155070542873347.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,714 F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 20:53 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 30,780 | $57.61 Strike: $57.61 | $1,773,081.90 |
DisclosureSEC source: 0001022079-18-000155 · wf-form4_153142881491793.xml · derivative · entry 4 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,780 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 4, 2018. F5 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 27, 2013, the second on February 27, 2014 and the final on February 27, 2015. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 20:53 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 30,780 | $113.07 | $3,480,140.70 |
DisclosureSEC source: 0001022079-18-000155 · wf-form4_153142881491793.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,791 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 4, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $113.00 to $113.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 20:53 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 30,780 | $57.61 | $1,773,081.90 |
DisclosureSEC source: 0001022079-18-000155 · wf-form4_153142881491793.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 4, 2018. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 00:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 4,128 | $101.00 | $416,928.00 |
DisclosureSEC source: 0001022079-18-000090 · wf-form4_152038328352378.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,771 F4 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 29, 2016. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 4,006 | $101.00 | $404,606.00 |
DisclosureSEC source: 0001022079-18-000090 · wf-form4_152038328352378.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,899 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 8,134 | $101.00 | $821,534.00 |
DisclosureSEC source: 0001022079-18-000090 · wf-form4_152038328352378.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,900 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 23, 2015, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:08 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 496 | $104.99 | $52,075.04 |
DisclosureSEC source: 0001022079-18-000070 · wf-form4_151994208816390.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,766 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 29, 2016. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:08 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 927 | $104.10 | $96,500.70 |
DisclosureSEC source: 0001022079-18-000070 · wf-form4_151994208816390.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,262 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 29, 2016. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:08 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 482 | $101.43 | $48,889.26 |
DisclosureSEC source: 0001022079-18-000070 · wf-form4_151994208816390.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,189 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:53 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 900 | $101.43 | $91,287.00 |
DisclosureSEC source: 0001022079-18-000056 · wf-form4_151976838822037.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,671 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:53 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 317 | $102.69 | $32,552.73 |
DisclosureSEC source: 0001022079-18-000056 · wf-form4_151976838822037.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,571 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 28,690 | $0.00 Strike: $103.57 | $0.00 |
DisclosureSEC source: 0001022079-18-000020 · wf-form4_151925918194420.xml · derivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,690 Underlying: Common Stock · 28,690 shares Expires 2028-02-19 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,511 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000020 · wf-form4_151925918194420.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,888 F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:18 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 28,500 | $56.82 Strike: $56.82 | $1,619,370.00 |
DisclosureSEC source: 0001022079-17-000120 · wf-form4_149306509747504.xml · derivative · entry 7 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,500 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. F5 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 15, 2012, the second on February 15, 2013 and the final on February 15, 2014. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:18 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 1,013 | $55.65 Strike: $55.65 | $56,373.45 |
DisclosureSEC source: 0001022079-17-000120 · wf-form4_149306509747504.xml · derivative · entry 6 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,013 shares Expires 2020-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. F4 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 10, 2011, the second on February 10, 2012 and the final on February 10, 2013. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:18 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 28,500 | $100.00 | $2,850,000.00 |
DisclosureSEC source: 0001022079-17-000120 · wf-form4_149306509747504.xml · nonDerivative · entry 4 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,327 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:18 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 28,500 | $56.82 | $1,619,370.00 |
DisclosureSEC source: 0001022079-17-000120 · wf-form4_149306509747504.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:18 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,013 | $100.00 | $101,300.00 |
DisclosureSEC source: 0001022079-17-000120 · wf-form4_149306509747504.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,322 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 20:18 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 1,013 | $55.65 | $56,373.45 |
DisclosureSEC source: 0001022079-17-000120 · wf-form4_149306509747504.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 13,987 | $55.65 Strike: $55.65 | $778,376.55 |
DisclosureSEC source: 0001022079-17-000107 · wf-form4_149004220633264.xml · derivative · entry 4 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,013 Underlying: Common Stock · 13,987 shares Expires 2020-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. F3 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 10, 2011, the second on February 10, 2012 and the final on February 10, 2013. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 13,987 | $100.00 | $1,398,700.00 |
DisclosureSEC source: 0001022079-17-000107 · wf-form4_149004220633264.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,322 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 13,987 | $55.65 | $778,376.55 |
DisclosureSEC source: 0001022079-17-000107 · wf-form4_149004220633264.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 21:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 4,478 | $98.29 | $440,142.62 |
DisclosureSEC source: 0001022079-17-000105 · wf-form4_148883643050293.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,322 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 22, 2016. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:15 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 4,824 | $98.12 | $473,330.88 |
DisclosureSEC source: 0001022079-17-000101 · wf-form4_148857932530003.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,800 F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F4 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:15 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 9,302 | $98.12 | $912,712.24 |
DisclosureSEC source: 0001022079-17-000101 · wf-form4_148857932530003.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,619 F2 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 13, 2014, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 22:15 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 470 | $97.77 | $45,951.90 |
DisclosureSEC source: 0001022079-17-000101 · wf-form4_148857932530003.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,317 F1 · shares: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 22, 2016. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:43 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 507 | $96.42 | $48,884.94 |
DisclosureSEC source: 0001022079-17-000082 · wf-form4_148849100899652.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,787 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 21:49 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 440 | $97.39 | $42,851.60 |
DisclosureSEC source: 0001022079-17-000070 · wf-form4_148831856624853.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,294 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 22, 2016. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:49 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 474 | $95.68 | $45,352.32 |
DisclosureSEC source: 0001022079-17-000070 · wf-form4_148831856624853.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,734 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:16 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 32,551 | $95.80 Strike: $95.80 | $3,118,223.05 |
DisclosureSEC source: 0001022079-17-000050 · wf-form4_148789178780845.xml · derivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,551 Underlying: Common Stock · 32,551 shares Expires 2027-02-21 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.